Copyright Reports & Markets. All rights reserved.

Global Citicoline Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Citicoline Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Injection
    • 1.3.3 Tablets
    • 1.3.4 Capsule
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Citicoline Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharma
    • 1.4.3 Non-pharma
  • 1.5 Global Citicoline Market Size & Forecast
    • 1.5.1 Global Citicoline Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Citicoline Sales Quantity (2021-2032)
    • 1.5.3 Global Citicoline Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Union Korea Pharm
    • 2.1.1 Union Korea Pharm Details
    • 2.1.2 Union Korea Pharm Major Business
    • 2.1.3 Union Korea Pharm Citicoline Product and Services
    • 2.1.4 Union Korea Pharm Citicoline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Union Korea Pharm Recent Developments/Updates
  • 2.2 Century Pharma
    • 2.2.1 Century Pharma Details
    • 2.2.2 Century Pharma Major Business
    • 2.2.3 Century Pharma Citicoline Product and Services
    • 2.2.4 Century Pharma Citicoline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Century Pharma Recent Developments/Updates
  • 2.3 Invision Medi Sciences
    • 2.3.1 Invision Medi Sciences Details
    • 2.3.2 Invision Medi Sciences Major Business
    • 2.3.3 Invision Medi Sciences Citicoline Product and Services
    • 2.3.4 Invision Medi Sciences Citicoline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Invision Medi Sciences Recent Developments/Updates
  • 2.4 Rasco Life Sciences
    • 2.4.1 Rasco Life Sciences Details
    • 2.4.2 Rasco Life Sciences Major Business
    • 2.4.3 Rasco Life Sciences Citicoline Product and Services
    • 2.4.4 Rasco Life Sciences Citicoline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Rasco Life Sciences Recent Developments/Updates
  • 2.5 RPG Life Sciences Ltd
    • 2.5.1 RPG Life Sciences Ltd Details
    • 2.5.2 RPG Life Sciences Ltd Major Business
    • 2.5.3 RPG Life Sciences Ltd Citicoline Product and Services
    • 2.5.4 RPG Life Sciences Ltd Citicoline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 RPG Life Sciences Ltd Recent Developments/Updates
  • 2.6 Chemo Biological
    • 2.6.1 Chemo Biological Details
    • 2.6.2 Chemo Biological Major Business
    • 2.6.3 Chemo Biological Citicoline Product and Services
    • 2.6.4 Chemo Biological Citicoline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Chemo Biological Recent Developments/Updates
  • 2.7 Harbin Pharm. Group Sanjing Pharmaceutical
    • 2.7.1 Harbin Pharm. Group Sanjing Pharmaceutical Details
    • 2.7.2 Harbin Pharm. Group Sanjing Pharmaceutical Major Business
    • 2.7.3 Harbin Pharm. Group Sanjing Pharmaceutical Citicoline Product and Services
    • 2.7.4 Harbin Pharm. Group Sanjing Pharmaceutical Citicoline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Harbin Pharm. Group Sanjing Pharmaceutical Recent Developments/Updates
  • 2.8 Innova
    • 2.8.1 Innova Details
    • 2.8.2 Innova Major Business
    • 2.8.3 Innova Citicoline Product and Services
    • 2.8.4 Innova Citicoline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Innova Recent Developments/Updates

3 Competitive Environment: Citicoline by Manufacturer

  • 3.1 Global Citicoline Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Citicoline Revenue by Manufacturer (2021-2026)
  • 3.3 Global Citicoline Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Citicoline by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Citicoline Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Citicoline Manufacturer Market Share in 2025
  • 3.5 Citicoline Market: Overall Company Footprint Analysis
    • 3.5.1 Citicoline Market: Region Footprint
    • 3.5.2 Citicoline Market: Company Product Type Footprint
    • 3.5.3 Citicoline Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Citicoline Market Size by Region
    • 4.1.1 Global Citicoline Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Citicoline Consumption Value by Region (2021-2032)
    • 4.1.3 Global Citicoline Average Price by Region (2021-2032)
  • 4.2 North America Citicoline Consumption Value (2021-2032)
  • 4.3 Europe Citicoline Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Citicoline Consumption Value (2021-2032)
  • 4.5 South America Citicoline Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Citicoline Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Citicoline Sales Quantity by Type (2021-2032)
  • 5.2 Global Citicoline Consumption Value by Type (2021-2032)
  • 5.3 Global Citicoline Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Citicoline Sales Quantity by Application (2021-2032)
  • 6.2 Global Citicoline Consumption Value by Application (2021-2032)
  • 6.3 Global Citicoline Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Citicoline Sales Quantity by Type (2021-2032)
  • 7.2 North America Citicoline Sales Quantity by Application (2021-2032)
  • 7.3 North America Citicoline Market Size by Country
    • 7.3.1 North America Citicoline Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Citicoline Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Citicoline Sales Quantity by Type (2021-2032)
  • 8.2 Europe Citicoline Sales Quantity by Application (2021-2032)
  • 8.3 Europe Citicoline Market Size by Country
    • 8.3.1 Europe Citicoline Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Citicoline Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Citicoline Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Citicoline Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Citicoline Market Size by Region
    • 9.3.1 Asia-Pacific Citicoline Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Citicoline Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Citicoline Sales Quantity by Type (2021-2032)
  • 10.2 South America Citicoline Sales Quantity by Application (2021-2032)
  • 10.3 South America Citicoline Market Size by Country
    • 10.3.1 South America Citicoline Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Citicoline Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Citicoline Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Citicoline Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Citicoline Market Size by Country
    • 11.3.1 Middle East & Africa Citicoline Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Citicoline Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Citicoline Market Drivers
  • 12.2 Citicoline Market Restraints
  • 12.3 Citicoline Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Citicoline and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Citicoline
  • 13.3 Citicoline Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Citicoline Typical Distributors
  • 14.3 Citicoline Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Citicoline market size was valued at US$ 449 million in 2025 and is forecast to a readjusted size of US$ 1118 million by 2032 with a CAGR of 14.1% during review period.
    Citicoline (cytidine diphosphocholine, CDP-choline) is a novel nutrient with a broad spectrum of benefits for conditions associated with symptoms of neurological dysfunction. An endogenous compound, citicoline is an essential intermediate in the synthesis of cell membrane phospholipids and its formation is the rate-limiting step in phosphatidylcholine synthesis. It plays several important roles in human physiology, including enhancement of structural integrity and signaling for cell membranes, support of acetylcholine synthesis, and synthesis of betaine, a methyl donor. Citicoline provides the brain with a source of choline and cytidine, which are efficiently used in the Kennedy cycle to generate phospholipids. It is able to attenuate the production of free radicals in ischemic conditions, while it also stimulates glutathione synthesis and the activity of glutathione reductase. Studies in animals and humans provide evidence of citicoline’s ability to promote learning and memory and improve cognitive impairment in Alzheimer’s and Parkinson’s disease, as well as in victims of mild to moderate stroke and cerebral ischemia. Citicoline administration may also reduce the duration of coma and the severity of mental and motor deficits associated with traumatic head injuries.
    As a medicine, it is taken by mouth as a supplement or given by IV or as a shot. Citicoline is used for Alzheimer"s disease and other types of dementia, head trauma, cerebrovascular disease such as stroke, age-related memory loss, Parkinson"s disease, attention deficit-hyperactive disorder (ADHD), and glaucoma.
    Citicoline was originally developed in Japan for stroke. It was later introduced as a prescription drug in many European countries. In these countries it is now frequently prescribed for thinking problems related to circulation problems in the brain. In the US, citicoline is marketed as a dietary supplement.
    Global Citicoline key players include Union Korea Pharm, Century Pharma, Invision Medi Sciences, etc.
    In terms of application, the largest application is Pharma, with a share over 85%, followed by Non-pharma.
    This report is a detailed and comprehensive analysis for global Citicoline market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Citicoline market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Ton), 2021-2032
    Global Citicoline market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Ton), 2021-2032
    Global Citicoline market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Ton), 2021-2032
    Global Citicoline market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (USD/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Citicoline
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Citicoline market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Union Korea Pharm, Century Pharma, Invision Medi Sciences, Rasco Life Sciences, RPG Life Sciences Ltd, Chemo Biological, Harbin Pharm. Group Sanjing Pharmaceutical, Innova, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Citicoline market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Injection
    Tablets
    Capsule
    Market segment by Application
    Pharma
    Non-pharma
    Major players covered
    Union Korea Pharm
    Century Pharma
    Invision Medi Sciences
    Rasco Life Sciences
    RPG Life Sciences Ltd
    Chemo Biological
    Harbin Pharm. Group Sanjing Pharmaceutical
    Innova
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Citicoline product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Citicoline, with price, sales quantity, revenue, and global market share of Citicoline from 2021 to 2026.
    Chapter 3, the Citicoline competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Citicoline breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Citicoline market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Citicoline.
    Chapter 14 and 15, to describe Citicoline sales channel, distributors, customers, research findings and conclusion.

    Buy now